ClinicalTrials.gg
RecruitingNCT07662421Updated Sep 3, 2026

Slump Lateral Bending Test Diagnostic Accuracy in Lumbar Radicular Pain

An observational study in Peripheral Neurogenic Pain, sponsored by Fisiopoint Parma Physiotherapy. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Fisiopoint Parma Physiotherapy · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
280
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 213 studies in Pain with a site in Italy — 35 open to participants now, 41 under way, 1 of them phase 3. Pain · Italy.

Planned enrollment
13th of 56
280 · median 142
Started
2026
with 7 others
Observational
57 of 213
20 open now
Primary completion
2029-06
later than 39 of 40 live
Registered
208th of 213
by date

Among the 213 studies in Pain with a site in Italy, this one is the 13th largest by planned enrollment of the 56 observational ones that give a count, is one of 8 that started in 2026, is one of 57 observational ones, reaches primary completion later than 39 of the 40 other live ones, and was the 208th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

35 of the 213 studies in Pain with a site in Italy are open now. Recruiting first, the newest first:

29 more — sign in →

All 35 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 213 studies in Pain with a site in Italy, or all of them as a file.
02

Study summary

This observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, including the Slump Lateral Bending Test and other neurological and neurodynamic findings. Thes study aims to determine whether this test may help clinicians recognize patients in whom peripheral nerve involvement contributes to symptoms. The results may support clinical reasoning in physiotherapy and improve the assessment o patients with suspected neurogenic pain.

03

Conditions studied

  • Peripheral Neurogenic Pain

Browse trials for

Keywords

  • Slump Lateral Bending Test, Neurodynamic test, Peripheral neurogenic pain,
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with suspected peripheral neurogenic pain or neural mechanosensitivity who are referred for physiotherapy assessment will be considered for inclusion. Participants may present with symptoms such as pain, paresthesia, dysesthesia, or movement-related symptoms potentially associated with peripheral nerve involvement. Eligible patients will undergo a standardized clinical assessment including neurological and neurodynamic examination procedures, including the Slump Lateral Bending Test.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • Patients with suspected peripheral neurogenic pain or neural mechanosensitivity.
  • Presence of symptoms potentially related to peripheral nerve involvement, such as:
  • pain;
  • paresthesia;
  • dysesthesia;
  • symptoms modified by neurodynamic positioning.
  • Ability to understand the study procedures and provide written .
  • Ability to undergo the clinical, neurological, and neurodynamic assessment procedures required by the study.

Exclusion criteria

Exclusion Criteria

  • Age under 18 years.
  • Inability to provide .
  • Presence of severe neurological disease or central nervous system disorder that may interfere with clinical assessment.
  • Previous major surgery or trauma affecting the assessed body region, if it may compromise interpretation of the clinical tests.
  • Acute inflammatory, infectious, or systemic disease that may explain the symptoms or contraindicate clinical testing.
  • Severe pain or clinical condition preventing safe execution of the Slump Lateral Bending Test or other neurodynamic tests.
  • Pregnancy, if neurodynamic testing is considered inappropriate or not clinically indicated.
  • Inability to understand instructions or complete the assessment procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
280 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Sensitivity and Specificity of the SLBT for MRI-Confirmed Lumbar Nerve Root Contact or Compression

    Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, and overall diagnostic accuracy of the Slump Lateral Bending Test will be calculated using lumbar MRI findings classified as nerve root contact or compression as the reference standard.

    Time frame: At baseline

07

Study locations

1 of 1 sites recruiting
  • Fisiopoint Parma
    Parma, PR 43125, Italy
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jun 2029, 35 months after the start.

Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's planned 35 months is above that.

Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2026
First posted
Jun 23, 2026
StartActual
Jun 23, 2026
Primary completionEst.
Jun 15, 2029
CompletionEst.
Jun 15, 2029
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07662421
Lead sponsor
Fisiopoint Parma Physiotherapy
Responsible party
Sponsor
First posted
Jun 23, 2026
Start date
Jun 23, 2026
Primary completion
Jun 15, 2029 (estimated)
Completion
Jun 15, 2029 (estimated)
Last update
Sep 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion